Power Law company profile

Intersect ENT

Biotech & Life Sciences · Menlo Park, United States · Founded 2003 · IPO 2014 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$813M

Market cap · 2026

Revenue

$160M

Latest reported FY

Investors

2 investors on Intersect ENT's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 2 investors entered at this stage

U.S. Venture Partners

Kleiner Perkins

Global footprint

Where Intersect ENT has talent and traffic

Web traffic by country

70 monthly visits
across markets

🇺🇸 United States142.9%

Top 1 markets shown

Patent intelligence

$70M patent portfolio · 39 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$70M

8.6% of market cap · 13.2× smaller than top peer Globus Medical ($930M)

39 active patent families

Where Intersect ENT innovates Medical instrumentsMedical physicsBiomedical engineeringGeneral surgeryPharmaceutical drug

Above peer median on Market

Quality vs same-sector peers

Intersect ENT on the five Patsnap quality dimensions

Intersect ENT in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Intersect ENT concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Intersect ENT and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Intersect ENT on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo